T and NK Cell Phenotypic Abnormalities in Systemic Sclerosis: a Cohort Study and a Comprehensive Literature Review

被引:42
作者
Almeida, Isabel [1 ,4 ]
Silva, Sara Vieira [1 ]
Fonseca, Ana Raquel [2 ]
Silva, Ivone [1 ,3 ]
Vasconcelos, Carlos [1 ,4 ]
Lima, Margarida [2 ,4 ]
机构
[1] Ctr Hosp Porto, Hosp Santo Antonio, Dept Med, Clin Immunol Unit, P-4099001 Oporto, Portugal
[2] Ctr Hosp Porto, Hosp Santo Antonio, Dept Haematol, Lab Cytometry, P-4099001 Oporto, Portugal
[3] Ctr Hosp Porto, Hosp Santo Antonio, Dept Vasc Surg, P-4099001 Oporto, Portugal
[4] Univ Porto, Inst Ciencias Biomed Abel Salazar, Multidisciplinary Unit Biomed Investigat UMIB, P-4100 Oporto, Portugal
关键词
Systemic sclerosis; T cells; CD8; CD4; CD56; NK cells; Cytokines; INTERSTITIAL LUNG-DISEASE; INCREASED FREQUENCY; PERIPHERAL-BLOOD; TH17; CELLS; CLASSIFICATION CRITERIA; SCLERODERMA FIBROBLASTS; LYMPHOCYTE HOMEOSTASIS; AUTOIMMUNE-DISEASES; RAYNAUDS-PHENOMENON; DERMAL FIBROBLASTS;
D O I
10.1007/s12016-015-8505-8
中图分类号
R392 [医学免疫学];
学科分类号
100108 [医学免疫学];
摘要
Scleroderma (SSc) is a rare and heterogeneous immune-mediated disease involving the connective tissue and microvasculature whose pathogenesis remains unclear. Data concerning T and natural killer (NK) cell abnormalities and cytokine levels in the peripheral blood (PB) from patients with SSc are scarce, and the results are contradictory. The present study aimed to analyze the changes of T lymphocytes, NK cells, and T helper (Th)-related cytokines in the PB of patients with SSc in comparison to healthy individuals and its relation to disease subtype and stage, organ involvement, and nailfold capillaroscopic changes. A non-random convenience sample of 57 scleroderma patients was utilized. Fifty-five out of the 57 patients studied were women (97 %); 10 patients presented pre-scleroderma (pre-SSc) and 47 SSc: 34 limited cutaneous SSc (lcSSc) and 13 diffuse cutaneous SSc (dcSSc). Patients with SSc were classified in early (n = 7), intermediate (n = 10), and late (n = 30) disease. Blood samples were analyzed by flow cytometry for total T cells, CD4+ and CD8+ T cell subsets, total NK cells, and CD56+low and CD56+high NK cell subsets. T cells were further analyzed for the expression of the CD56 adhesion molecule and activation-related markers (HLA-DR, CD45RO). In addition, the serum levels of Th1-, Th2-, and Th17-related cytokines were measured by flow cytometry. Twenty-five healthy individuals recruited from the blood bank were used as controls. Patients had lower numbers of total lymphocytes and T cells comparing to healthy controls. Both CD4+ and CD8+ T cells were decreased, but differences were statistically significant only for CD8+ and CD8+ CD45RO+ T cells. These alterations were seen in patients with SSc but not in patients with pre-SSc, and, in general, they were more pronounced in patients with dcSSc than in patients with lcSSc, in patients with vascular involvement than in those without, as well as in patients having active and late nailfold capillaroscopic patterns. CD56+ T cells were also decreased in SSc patients, especially in those with active/late capillaroscopic patterns or with severe lung disease. Diminished numbers of circulating NK cells were also observed in patients with lcSSc and in those with early disease. No statistically significant changes were found in serum cytokine levels, as compared with controls. Patients with SSc had major alterations in circulating CD8+ and CD56+ T cells, as well as in NK cells, suggesting that these cells may play a relevant role in SSc pathogenesis, probably operating at different phases and/or at different organs. In addition, the serum levels of Th1, Th2, and Th17 cytokines did not provide useful information for evaluating T cell polarization in SSc.
引用
收藏
页码:347 / 369
页数:23
相关论文
共 116 条
[1]
Overview of pathogenesis of systemic sclerosis [J].
Abraham, D. J. ;
Krieg, T. ;
Distler, J. ;
Distler, O. .
RHEUMATOLOGY, 2009, 48 :3-7
[2]
PRELIMINARY CRITERIA FOR THE CLASSIFICATION OF SYSTEMIC-SCLEROSIS (SCLERODERMA) [J].
不详 .
ARTHRITIS AND RHEUMATISM, 1980, 23 (05) :581-590
[3]
[Anonymous], FRONTIERS BIOSCIENCE
[4]
Is scleroderma an autoantibody mediated disease? [J].
Arnett, Frank C. .
CURRENT OPINION IN RHEUMATOLOGY, 2006, 18 (06) :579-581
[5]
Immunology of systemic sclerosis [J].
Artlett, CM .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2005, 10 :1707-1719
[6]
Atamas SP, 1999, ARTHRITIS RHEUM, V42, P1168, DOI 10.1002/1529-0131(199906)42:6<1168::AID-ANR13>3.0.CO
[7]
2-L
[8]
Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group [J].
Avouac, J. ;
Fransen, J. ;
Walker, U. A. ;
Riccieri, V. ;
Smith, V. ;
Muller, C. ;
Miniati, I. ;
Tarner, I. H. ;
Bellando Randone, S. ;
Cutolo, M. ;
Allanore, Y. ;
Distler, O. ;
Valentini, G. ;
Czirjak, L. ;
Mueller-Ladner, U. ;
Furst, D. E. ;
Tyndall, A. ;
Matucci-Cerinic, M. .
ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (03) :476-481
[9]
Baroni SS, 2006, NEW ENGL J MED, V354, P2667
[10]
Emerging Roles of Innate Immune Signaling and Toll-Like Receptors in Fibrosis and Systemic Sclerosis [J].
Bhattacharyya, Swati ;
Varga, John .
CURRENT RHEUMATOLOGY REPORTS, 2015, 17 (01)